These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 22000927)
21. Effects of active commuting and leisure-time exercise on appetite in individuals with overweight and obesity. Quist JS; Blond MB; Gram AS; Steenholt CB; Janus C; Holst JJ; Rehfeld JF; Sjödin A; Stallknecht B; Rosenkilde M J Appl Physiol (1985); 2019 Apr; 126(4):941-951. PubMed ID: 30605397 [TBL] [Abstract][Full Text] [Related]
22. Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects. Sloth B; Holst JJ; Flint A; Gregersen NT; Astrup A Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1062-8. PubMed ID: 17148749 [TBL] [Abstract][Full Text] [Related]
23. Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects. Steinert RE; Poller B; Castelli MC; Drewe J; Beglinger C Am J Clin Nutr; 2010 Oct; 92(4):810-7. PubMed ID: 20720259 [TBL] [Abstract][Full Text] [Related]
24. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. Toft-Nielsen MB; Madsbad S; Holst JJ Diabetes Care; 1999 Jul; 22(7):1137-43. PubMed ID: 10388979 [TBL] [Abstract][Full Text] [Related]
25. The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics. Lee A; Patrick P; Wishart J; Horowitz M; Morley JE Diabetes Obes Metab; 2002 Sep; 4(5):329-35. PubMed ID: 12190996 [TBL] [Abstract][Full Text] [Related]
26. Selective FFA2 Agonism Appears to Act via Intestinal PYY to Reduce Transit and Food Intake but Does Not Improve Glucose Tolerance in Mouse Models. Forbes S; Stafford S; Coope G; Heffron H; Real K; Newman R; Davenport R; Barnes M; Grosse J; Cox H Diabetes; 2015 Nov; 64(11):3763-71. PubMed ID: 26239054 [TBL] [Abstract][Full Text] [Related]
27. Gut hormone activity of children born to women with and without gestational diabetes. Chandler-Laney PC; Bush NC; Rouse DJ; Mancuso MS; Gower BA Pediatr Obes; 2014 Feb; 9(1):53-62. PubMed ID: 23364910 [TBL] [Abstract][Full Text] [Related]
28. Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats. Chelikani PK; Haver AC; Reidelberger RD Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1695-706. PubMed ID: 15718384 [TBL] [Abstract][Full Text] [Related]
29. Effect of Macronutrient Composition on Appetite Hormone Responses in Adolescents with Obesity. Nguo K; Bonham MP; Truby H; Barber E; Brown J; Huggins CE Nutrients; 2019 Feb; 11(2):. PubMed ID: 30764560 [TBL] [Abstract][Full Text] [Related]
30. Intermittent intraperitoneal infusion of peptide YY(3-36) reduces daily food intake and adiposity in obese rats. Chelikani PK; Haver AC; Reidelberger RD Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R39-46. PubMed ID: 17428898 [TBL] [Abstract][Full Text] [Related]
31. Acute administration of capsaicin increases resting energy expenditure in young obese subjects without affecting energy intake, appetite, and circulating levels of orexigenic/anorexigenic peptides. Rigamonti AE; Casnici C; Marelli O; De Col A; Tamini S; Lucchetti E; Tringali G; De Micheli R; Abbruzzese L; Bortolotti M; Cella SG; Sartorio A Nutr Res; 2018 Apr; 52():71-79. PubMed ID: 29530622 [TBL] [Abstract][Full Text] [Related]
32. Influence of postexercise fasting on hunger and satiety in adults. Hamilton CC; Wiseman SB; Copeland JL; Bomhof MR Appl Physiol Nutr Metab; 2020 Sep; 45(9):1022-1030. PubMed ID: 32272024 [TBL] [Abstract][Full Text] [Related]
33. Peptide YY, appetite and food intake. le Roux CW; Bloom SR Proc Nutr Soc; 2005 May; 64(2):213-6. PubMed ID: 15960866 [TBL] [Abstract][Full Text] [Related]
34. Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males. Heruc GA; Horowitz M; Deacon CF; Feinle-Bisset C; Rayner CK; Luscombe-Marsh N; Little TJ Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E830-7. PubMed ID: 25231186 [TBL] [Abstract][Full Text] [Related]
35. Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Gutzwiller JP; Drewe J; Göke B; Schmidt H; Rohrer B; Lareida J; Beglinger C Am J Physiol; 1999 May; 276(5):R1541-4. PubMed ID: 10233049 [TBL] [Abstract][Full Text] [Related]
36. Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats. Reidelberger RD; Haver AC; Apenteng BA; Anders KL; Steenson SM Obesity (Silver Spring); 2011 Jan; 19(1):121-7. PubMed ID: 20559304 [TBL] [Abstract][Full Text] [Related]
37. Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Näslund E; Gutniak M; Skogar S; Rössner S; Hellström PM Am J Clin Nutr; 1998 Sep; 68(3):525-30. PubMed ID: 9734726 [TBL] [Abstract][Full Text] [Related]
38. Ghrelin attenuates the inhibitory effects of glucagon-like peptide-1 and peptide YY(3-36) on food intake and gastric emptying in rats. Chelikani PK; Haver AC; Reidelberger RD Diabetes; 2006 Nov; 55(11):3038-46. PubMed ID: 17065340 [TBL] [Abstract][Full Text] [Related]
39. Independent and combined effects of eating rate and energy density on energy intake, appetite, and gut hormones. Karl JP; Young AJ; Rood JC; Montain SJ Obesity (Silver Spring); 2013 Mar; 21(3):E244-52. PubMed ID: 23592679 [TBL] [Abstract][Full Text] [Related]
40. Effects of solid-phase extraction of plasma in measuring gut metabolic hormones in fasted and fed blood of lean and diet-induced obese rats. Reidelberger R; Haver A; Anders K; Apenteng B; Lanio C Physiol Rep; 2016 May; 4(10):. PubMed ID: 27207785 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]